449 related articles for article (PubMed ID: 21860412)
21. Altered methylation at microRNA-associated CpG islands in hereditary and sporadic carcinomas: a methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)-based approach.
Pavicic W; Perkiö E; Kaur S; Peltomäki P
Mol Med; 2011; 17(7-8):726-35. PubMed ID: 21327300
[TBL] [Abstract][Full Text] [Related]
22. CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer.
Ferreira HJ; Heyn H; Moutinho C; Esteller M
RNA Biol; 2012 Jun; 9(6):881-90. PubMed ID: 22617881
[TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
Su Y; Shetty A; Jiang F
Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
Ng HY; Wan TS; So CC; Chim CS
J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.
Lehmann U; Hasemeier B; Christgen M; Müller M; Römermann D; Länger F; Kreipe H
J Pathol; 2008 Jan; 214(1):17-24. PubMed ID: 17948228
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA Methylation in Colorectal Cancer.
Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C
Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115
[TBL] [Abstract][Full Text] [Related]
29. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M; Kozaki KI; Tanaka S; Arii S; Imoto I; Inazawa J
Carcinogenesis; 2010 May; 31(5):766-76. PubMed ID: 19843643
[TBL] [Abstract][Full Text] [Related]
30. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer.
Esteller M
Adv Exp Med Biol; 2003; 532():39-49. PubMed ID: 12908548
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between miRNAs and DNA Methylation in Cancer.
Saviana M; Le P; Micalo L; Del Valle-Morales D; Romano G; Acunzo M; Li H; Nana-Sinkam P
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239435
[TBL] [Abstract][Full Text] [Related]
32. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
Wang LQ; Liang R; Chim CS
Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic targets in human neoplasms.
Fandy TE; Gore SD
Epigenomics; 2010 Apr; 2(2):221-32. PubMed ID: 22121872
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.
Agirre X; Vilas-Zornoza A; Jiménez-Velasco A; Martin-Subero JI; Cordeu L; Gárate L; San José-Eneriz E; Abizanda G; Rodríguez-Otero P; Fortes P; Rifón J; Bandrés E; Calasanz MJ; Martín V; Heiniger A; Torres A; Siebert R; Román-Gomez J; Prósper F
Cancer Res; 2009 May; 69(10):4443-53. PubMed ID: 19435910
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer.
Tsai KW; Wu CW; Hu LY; Li SC; Liao YL; Lai CH; Kao HW; Fang WL; Huang KH; Chan WC; Lin WC
Int J Cancer; 2011 Dec; 129(11):2600-10. PubMed ID: 21960261
[TBL] [Abstract][Full Text] [Related]
36. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation and microRNA dysregulation in cancer.
Suzuki H; Maruyama R; Yamamoto E; Kai M
Mol Oncol; 2012 Dec; 6(6):567-78. PubMed ID: 22902148
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of microRNA genes and the role of miR-34b in cell invasion and motility in human melanoma.
Mazar J; Khaitan D; DeBlasio D; Zhong C; Govindarajan SS; Kopanathi S; Zhang S; Ray A; Perera RJ
PLoS One; 2011; 6(9):e24922. PubMed ID: 21949788
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.
Bi C; Chung TH; Huang G; Zhou J; Yan J; Ahmann GJ; Fonseca R; Chng WJ
Oncotarget; 2015 Sep; 6(28):26508-18. PubMed ID: 26164366
[TBL] [Abstract][Full Text] [Related]
40. The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma.
Paczkowska J; Janiszewska J; Bein J; Schneider M; Bednarek K; Ustaszewski A; Hartmann S; Hansmann ML; Giefing M
Cells; 2020 Oct; 9(10):. PubMed ID: 33066457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
